Analyst Ratings for Gossamer Bio Inc. (GOSS)
GOSS Rating Summary
GOSS Price Target Summary
- Highest: $9.00 (UBS)
- Lowest: $0.28 (Barclays)
- Average: $3.31
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$3.31 (+1846.4%)
* Over Last 12-Mos
Rating Score: 5.3 / 10
Percentile Rank: 56%
Avg. $ Target:
$3.31 (+1846.4%)
* Over Last 12-Mos
Rating Score: 5.3 / 10
Percentile Rank: 56%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/28/2026 | Leerink | Joseph Schwartz | Upgrade | Outperform (Market Perform) |
1.00 (N/A) |
0.14 (0.17) |
21.43% | Details |
| 3/23/2026 | Cantor Fitzgerald | Olivia Brayer | Downgrade | Neutral (Overweight) |
N/A (N/A) |
0.45 (0.17) |
-62.22% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
